Info

European Intergroup 51 39 28% 2-year OS 31

Study moderate prognosis half-dose CHOP arm

Table 61.2 Table of Phase II chemotherapy studies from the pre-HAART era

Regimen

Patients treated

Median CD4 count (per mm3)

Complete remission (%)

Median survival (months)

0 0

Post a comment